(Drug Name) (Drug Form) (Drug Strength)
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

SITAVIG: Buccal tablet (50mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

ACYCLOVIR (ay SYE kloe veer) is an antiviral medicine. It is used to treat infections caused by herpes virus. This medicine will not cure herpes.

In-Depth Information

Sitavig 50mg Buccal Tablet

NDC: 687120049
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved





Storage Information
Protect from moisture
Store between 68 to 77 degrees F, excursions permitted 59 to 86 degrees F
Sitavig 50mg Buccal Tablet

Reported Side Effects for Sitavig 50mg Buccal Tablet

Mouth Ulcers Incidence:
1.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Skin Redness Incidence:
1.0%*
Severity: MODERATE
Onset: EARLY
Tiredness Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
2.2-3.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Compatible - This drug is generally safe to take by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with SITAVIG

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.